Mitral annular calcification (MAC) is a common condition in which calcium deposits accumulate around the heart's mitral valve. It is a degenerative process that is seen in elderly patients, and is often associated with cardiovascular disease. It can lead to a number of health problems, including an increased risk of stroke, heart attack, and heart failure. In this article, we will explore the impact of MAC on heart health, and discuss how it can be managed.
Mitral annular calcification is a condition in which calcium deposits accumulate around the heart's mitral valve. It is a degenerative process that is seen in elderly patients, and is often associated with cardiovascular disease. The mitral valve is a one-way valve that prevents blood from flowing backwards into the left atrium. When calcium builds up around the valve, it can cause it to become stiff and narrow, making it difficult for the valve to open and close properly. This can lead to a number of health problems, including an increased risk of stroke, heart attack, and heart failure.
There are several risk factors that may increase the likelihood of developing MAC. These include: • Age: MAC is more common in older individuals, and the risk increases with age. • Gender: Women are more likely to develop MAC than men. • Hypertension: High blood pressure can increase the risk of developing MAC. • Diabetes: People with diabetes are more likely to develop MAC. • Smoking: Smokers are more likely to develop MAC than non-smokers. • Family history: Having a family history of MAC may increase the risk. • Diet: A diet high in saturated fats and low in calcium and vitamin D can increase the risk of MAC.
The symptoms of MAC vary from person to person, but can include: • Shortness of breath • Fatigue • Palpitations • Chest pain • Swelling of the feet and ankles • Dizziness or fainting • Irregular heartbeat
The diagnosis of MAC is typically made using echocardiography, a type of ultrasound that uses soundwaves to create images of the heart. Other tests, such as a chest X-ray, electrocardiogram, or cardiac catheterization, may also be used to diagnose MAC.
The treatment of MAC depends on the severity of the condition. In some cases, lifestyle changes, such as quitting smoking, controlling blood pressure, and eating a healthy diet, may be enough to manage the condition. In more severe cases, medications, such as diuretics, ACE inhibitors, and beta blockers, may be prescribed to reduce the risk of complications. In some cases, surgery may be necessary to repair or replace the mitral valve.
Mitral annular calcification is a common condition in which calcium deposits accumulate around the heart's mitral valve. It is a degenerative process that is seen in elderly patients, and is often associated with cardiovascular disease. It can lead to a number of health problems, including an increased risk of stroke, heart attack, and heart failure. The risk factors, symptoms, diagnosis, and treatment of MAC will vary from person to person, but it is important to be aware of the condition and take steps to manage it.
1.
Cardiorespiratory fitness lowers the risk of colon, lung, and prostate cancer in MEN and lowers mortality from these diseases.
2.
Chemo causes lasting physical decline in breast cancer survivors
3.
VP Nominee Medical Records Breached; Queen Elizabeth's Cancer; Galaxy Gas Whippets
4.
Race, Geography Linked to Gaps in Prostate Cancer Care
5.
DNA origami offers more accurate imaging in the fight against pancreatic cancer
1.
Patient Management After Personalized Surgical Oncology Reconstruction
2.
Clinical Methods in Hematology and Quality Improvement
3.
Bispecific Antibodies in Hematologic Malignancies: Mechanisms, Clinical Applications, and Future Directions
4.
Demystifying the Mentzer Index: Understanding Its Importance in Inventory Management
5.
Uncovering the Hidden Symptoms of Parathyroid Cancer in Women
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding Platelet Disorders
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation